A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides ...

On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $52.8 which represents a decrease of $-0.59 or -1.11% from the prior close of $53.39. The stock opened at $53.39 and touched a ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

Scientists in Australia have found why mRNA vaccines trigger side effects, paving the way for more effective vaccines.

With exclusive FDA insight, the 4th mRNA Analytical Development & Quality Control Summit returns; uniting the Analytical, ...

As one of the leading causes of acute gastroenteritis worldwide, NoV is associated with a substantial healthcare burden.

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...